Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia

Ayalew Tefferi, Chris R. Schad, Rajiv K. Pruthi, Gregory J. Ahmann, Jack L. Spurbeck, Gordon W. Dewald

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Using immunomagnetic cell separation and fluorescent in situ hybridization (FISH), we studied nine patients who had chronic granulocytic leukemia (CGL) for the proportion of interphase nuclei with Mbcr/abl fusion in a direct preparation of the bone marrow and also in the mononuclear cell (MNC), neutrophil, and B- and T-cell fractions of the peripheral blood. In five untreated patients, conventional cytogenetics revealed 97% to 100% Philadelphia chromosome (Ph)+ metaphases. In three of these five patients, FISH studies on bone marrow direct preparations and peripheral blood MNCs indicated that an Mbcr/abl fusion occurred in 62% to 69% of the cells. We observed 69% to 88% of nuclei with Mbcr/abl fusion within the neutrophil fractions. In contrast, the values were 12% to 39% within the T-cell fractions in the four patients we studied. B-cell fractions were studied in three patients, and only one had an abnormal value (58%). In the four patients receiving α-interferon therapy, the degree of conventional cytogenetic remission correlated best with the degree of FISH remission observed in the peripheral blood neutrophil fraction. Our results are in agreement with earlier studies in that both B and T lymphocytes may be involved with the clonal process in CGL. The FISH-based detection of Mbcr/abl fusion in the peripheral blood neutrophil compartment provided the best estimate for the proportion of Ph metaphases determined by conventional cytogenetics.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume83
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Fluorescence In Situ Hybridization
Neutrophils
Lymphocytes
Cytogenetics
Metaphase
T-Lymphocytes
B-Lymphocytes
Bone Marrow
Immunomagnetic Separation
Philadelphia Chromosome
Interphase
Interferons

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. / Tefferi, Ayalew; Schad, Chris R.; Pruthi, Rajiv K.; Ahmann, Gregory J.; Spurbeck, Jack L.; Dewald, Gordon W.

In: Cancer Genetics and Cytogenetics, Vol. 83, No. 1, 1995, p. 61-64.

Research output: Contribution to journalArticle

Tefferi, Ayalew ; Schad, Chris R. ; Pruthi, Rajiv K. ; Ahmann, Gregory J. ; Spurbeck, Jack L. ; Dewald, Gordon W. / Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. In: Cancer Genetics and Cytogenetics. 1995 ; Vol. 83, No. 1. pp. 61-64.
@article{c84ba65b418648d596f268c053068383,
title = "Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia",
abstract = "Using immunomagnetic cell separation and fluorescent in situ hybridization (FISH), we studied nine patients who had chronic granulocytic leukemia (CGL) for the proportion of interphase nuclei with Mbcr/abl fusion in a direct preparation of the bone marrow and also in the mononuclear cell (MNC), neutrophil, and B- and T-cell fractions of the peripheral blood. In five untreated patients, conventional cytogenetics revealed 97{\%} to 100{\%} Philadelphia chromosome (Ph)+ metaphases. In three of these five patients, FISH studies on bone marrow direct preparations and peripheral blood MNCs indicated that an Mbcr/abl fusion occurred in 62{\%} to 69{\%} of the cells. We observed 69{\%} to 88{\%} of nuclei with Mbcr/abl fusion within the neutrophil fractions. In contrast, the values were 12{\%} to 39{\%} within the T-cell fractions in the four patients we studied. B-cell fractions were studied in three patients, and only one had an abnormal value (58{\%}). In the four patients receiving α-interferon therapy, the degree of conventional cytogenetic remission correlated best with the degree of FISH remission observed in the peripheral blood neutrophil fraction. Our results are in agreement with earlier studies in that both B and T lymphocytes may be involved with the clonal process in CGL. The FISH-based detection of Mbcr/abl fusion in the peripheral blood neutrophil compartment provided the best estimate for the proportion of Ph metaphases determined by conventional cytogenetics.",
author = "Ayalew Tefferi and Schad, {Chris R.} and Pruthi, {Rajiv K.} and Ahmann, {Gregory J.} and Spurbeck, {Jack L.} and Dewald, {Gordon W.}",
year = "1995",
doi = "10.1016/0165-4608(95)00036-4",
language = "English (US)",
volume = "83",
pages = "61--64",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia

AU - Tefferi, Ayalew

AU - Schad, Chris R.

AU - Pruthi, Rajiv K.

AU - Ahmann, Gregory J.

AU - Spurbeck, Jack L.

AU - Dewald, Gordon W.

PY - 1995

Y1 - 1995

N2 - Using immunomagnetic cell separation and fluorescent in situ hybridization (FISH), we studied nine patients who had chronic granulocytic leukemia (CGL) for the proportion of interphase nuclei with Mbcr/abl fusion in a direct preparation of the bone marrow and also in the mononuclear cell (MNC), neutrophil, and B- and T-cell fractions of the peripheral blood. In five untreated patients, conventional cytogenetics revealed 97% to 100% Philadelphia chromosome (Ph)+ metaphases. In three of these five patients, FISH studies on bone marrow direct preparations and peripheral blood MNCs indicated that an Mbcr/abl fusion occurred in 62% to 69% of the cells. We observed 69% to 88% of nuclei with Mbcr/abl fusion within the neutrophil fractions. In contrast, the values were 12% to 39% within the T-cell fractions in the four patients we studied. B-cell fractions were studied in three patients, and only one had an abnormal value (58%). In the four patients receiving α-interferon therapy, the degree of conventional cytogenetic remission correlated best with the degree of FISH remission observed in the peripheral blood neutrophil fraction. Our results are in agreement with earlier studies in that both B and T lymphocytes may be involved with the clonal process in CGL. The FISH-based detection of Mbcr/abl fusion in the peripheral blood neutrophil compartment provided the best estimate for the proportion of Ph metaphases determined by conventional cytogenetics.

AB - Using immunomagnetic cell separation and fluorescent in situ hybridization (FISH), we studied nine patients who had chronic granulocytic leukemia (CGL) for the proportion of interphase nuclei with Mbcr/abl fusion in a direct preparation of the bone marrow and also in the mononuclear cell (MNC), neutrophil, and B- and T-cell fractions of the peripheral blood. In five untreated patients, conventional cytogenetics revealed 97% to 100% Philadelphia chromosome (Ph)+ metaphases. In three of these five patients, FISH studies on bone marrow direct preparations and peripheral blood MNCs indicated that an Mbcr/abl fusion occurred in 62% to 69% of the cells. We observed 69% to 88% of nuclei with Mbcr/abl fusion within the neutrophil fractions. In contrast, the values were 12% to 39% within the T-cell fractions in the four patients we studied. B-cell fractions were studied in three patients, and only one had an abnormal value (58%). In the four patients receiving α-interferon therapy, the degree of conventional cytogenetic remission correlated best with the degree of FISH remission observed in the peripheral blood neutrophil fraction. Our results are in agreement with earlier studies in that both B and T lymphocytes may be involved with the clonal process in CGL. The FISH-based detection of Mbcr/abl fusion in the peripheral blood neutrophil compartment provided the best estimate for the proportion of Ph metaphases determined by conventional cytogenetics.

UR - http://www.scopus.com/inward/record.url?scp=0029131153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029131153&partnerID=8YFLogxK

U2 - 10.1016/0165-4608(95)00036-4

DO - 10.1016/0165-4608(95)00036-4

M3 - Article

C2 - 7656207

AN - SCOPUS:0029131153

VL - 83

SP - 61

EP - 64

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -